Visitors and news

Mr Kossi Abalo, former fellow in the Screening Group, presented an oral presentation about the Impact of population-based breast cancer screening programmes on breast cancer mortality in the European Union Countries and a poster about the Coccinelle study and childhood cancer after exposure to medical imaging diagnostic procedures in childhood.

A postdoctoral opportunity is immediately available for an epidemiologist/biomedical researcher in the Screening Group. The research study includes a systematic review on the subject, organizing a survey on measurable indicators of inequalities in access to screening in Latin America and preparing manuscripts for publication.
View the postdoctoral opportunity.

Ms Trude Andreassen visited the Screening Group to work on an analysis of the factors determining women’s participation in cervical cancer screening programmes.

Twenty-four candidates from Albania, Azerbaijan, Georgia, Kosovo, Kyrgyzstan, Moldova, Serbia, Tajikistan, Ukraine and Uzbekistan sat an exit examination to complete the comprehensive, multimodal IFCPC/IARC course on colposcopy and cervical cancer prevention. This course is organized by the International Federation of Cervical Pathology and Colposcopy (IFCPC) in collaboration with IARC. The OSCE was supported by UNFPA Regional office for Eastern Europe and Central Asia.

This new article, published in the BMC Cancer in collaboration with Brazillian School of Medical Sciences of Unicamp, Campinas, examined temporal trends of stage distribution in women with breast cancer diagnosed between 2000 and 2015. The publication highlighted that breast cancer cases are diagnosed mainly at early stages and downstaging has been shown. opportunistic screening may have supported these results.
View the publication.

Dr Basu has been invited as speaker during the The British Society for Colposcopy and Cervical Pathology (BSCCP) annual scientific meeting and discussed about worldwide initiatives for prevention of cervical cancers and vaccination status in low-middle income countries.

Dr Yogesh Verma visited the Screening Group to work on an analysis and preparation of a new manuscript for the extended follow-up of the participants of the HPV vaccine trial to evaluate the effectiveness of one, two, and three doses of quadrivalent HPV vaccine in preventing cervical neoplasia.

IARC released this new fact sheet to summarize the benefits and harms of lung cancer screening with a modern protocol. View the fact sheet, the associated video and the recent article published in The Lancet Respiratory Medicine by Dr Paul Brennan team.

Dr Andre Carvalho participated in this workshop organized by the EU Cancer Leagues and CPO Piedmont with stakeholders from 11 EU Member states. He discussed how to embed health promotion and primary prevention into organized screening programmes, and how to measure the impact of prevention interventions into cancer screening programme.

Dr Partha Basu attended the AOGIN 2019 Conference “Move from Control to Elimination” and the 17th Annual Meeting of National Cervical Cancer Consortium on 27-28 April in Beijing, China. He presented the last data about efficacy of single dose of 4-valent HPV vaccine, updated results from the SCR Indian Study.